Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Helena Hognert"'
Publikováno v:
Reproductive, Female and Child Health, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract Objective To investigate if earlier and repeated postpartum care visits (PPCVs) (3 and 7 weeks) compared to a standard visit (7 weeks) would increase early initiation of contraception and contraceptive use at 1‐year postpartum. Design Comp
Externí odkaz:
https://doaj.org/article/835cb1b234ba4ca5974e94be5354864e
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/4452ddc9706a4c05b9e84f7900424c23
Autor:
Tagrid Jar-Allah, Helena Hognert, Laura Köcher, Linus Berggren, Christian Fiala, Ian Milsom, Kristina Gemzell-Danielsson
Publikováno v:
The European journal of contraceptionreproductive health care : the official journal of the European Society of Contraception. 27(3)
To evaluate the outcome of the very early medical abortion (VEMA) protocol and whether it could increase early diagnosis and treatment of an asymptomatic ectopic pregnancy (EP). To investigate serum β-hCG levels correlated to ultrasound findings, an
Autor:
Ingela Lindh, Finn Egil Skjeldestad, Oskari Heikinheimo, Helena Hognert, Øjvind Lidegaard, Christina Bergh, Kristina Gemzell‐Danielsson
Publikováno v:
Lindh, I, Skjeldestad, F E, Heikinheimo, O, Hognert, H, Lidegaard, Ø, Bergh, C & Gemzell-Danielsson, K 2022, ' Reproductive changes among women in their 40s : A cross-sectional study ', Acta Obstetricia et Gynecologica Scandinavica, vol. 101, no. 2, pp. 248-255 . https://doi.org/10.1111/aogs.14302
Introduction: The aim was to describe and compare changes in the reproductive pattern of women in their 40s observed over a decade in Scandinavia. Material and Methods: Cross-sectional study using the total population of women aged 40-49 years betwee
Publikováno v:
BMJ Open. 12:e054076
IntroductionAlthough considered an essential service by the WHO, there are indications that access to induced abortion care has been restricted during the COVID-19 pandemic.ObjectivesTo investigate if the number of induced abortions and ongoing pregn
Autor:
Ingela Lindh, Kristina Gemzell-Danielsson, Ian Milsom, Finn Egil Skjeldestad, Øjvind Lidegaard, Oskari Heikinheimo, Helena Hognert
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 96:1414-1422
INTRODUCTION: The aim was to describe and compare contraceptive use fertility birth and abortion rates in the Nordic countries. MATERIAL AND METHODS: National data on births abortions fertility rate (1975-2013) redeemed prescriptions of hormonal cont
Autor:
Ingrid Sääv, Christian Fiala, I Bizjak, Helena Hognert, L Berggren, J Bring, Kristina Gemzell-Danielsson
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology. 124:1993-1999
Objective To assess the efficacy and safety of medical termination of pregnancy (MTOP) when no intrauterine pregnancy (IUP) is confirmed on ultrasound. Design Retrospective case-note review. Setting Two gynaecological clinics in Vienna, Austria, and
Autor:
Helena Hognert, Finn Egil Skjeldestad, Ingela Lindh, Kristina Gemzell-Danielsson, Ian Milsom, Øjvind Lidegaard, Oskari Heikinheimo
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 96:19-28
Introduction The aim was to compare contraceptive use in the Nordic countries and to assess compliance with recommendations from the European Medicines Agency regarding the use of combined oral contraception containing low-dose estrogen and levonorge
Autor:
Helena, Hognert, Finn Egil, Skjeldestad, Kristina, Gemzell-Danielsson, Oskari, Heikinheimo, Ian, Milsom, Øjvind, Lidegaard, Ingela, Lindh
Publikováno v:
BMJ Open
Objectives Compare hormonal contraceptive use, birth and abortion rates among teenagers in the Nordic countries. A secondary aim was to explore plausible explanations for possible differences between countries. Design Ecological study using national
Autor:
Annette Aronsson, Rebecca Heller, Sharon Cameron, Helena Hognert, Kristina Gemzell-Danielsson, Izabella Jawad, Lina Benson, Ingela Lindh, Christina Nyrelli, Helena Kopp Kallner
Publikováno v:
Human reproduction (Oxford, England). 31(11)
STUDY QUESTION Does a progestin releasing subdermal contraceptive implant affect the efficacy of medical abortion if inserted at the same visit as the progesterone receptor modulator, mifepristone, at medical abortion? SUMMARY ANSWER A etonogestrel r